Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) ▲ | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc. | 55 | 2 | 8 | 0 | €436.60 | €436.84 | 0.054% |
| MorphoSys AG | 7 | 0 | 0 | 0 | €67.75 | €65.00 | -4.059% |
| QIAGEN NV | 11 | 0 | 3 | 0 | €40.47 | €47.44 | 17.223% |
| Regeneron Pharmaceuticals Inc. | 48 | 1 | 11 | 0 | €946.40 | €1,032.6 | 9.111% |
| AstraZeneca plc | 2 | 0 | 0 | 0 | €143.95 | €165.00 | 14.623% |
| Sanofi S.A. | 14 | 0 | 11 | 0 | €91.00 | €100.00 | 9.890% |
| Novo Nordisk A/S | 4 | 0 | 0 | 0 | €185.00 | €172.50 | -6.757% |
| Pfizer Inc. | 35 | 4 | 8 | 0 | €25.97 | €40.00 | 54.054% |
| Johnson & Johnson | 42 | 1 | 9 | 0 | €135.30 | €179.00 | 32.299% |
| Merck & Co. Inc. | 35 | 1 | 6 | 0 | €115.80 | €125.34 | 8.236% |
| Biogen Inc. | 57 | 1 | 8 | 0 | €208.10 | €291.49 | 40.073% |
| Amgen Inc. | 33 | 0 | 9 | 0 | €285.90 | €304.82 | 6.617% |
| Gilead Sciences Inc | 19 | 1 | 8 | 0 | €61.24 | €76.50 | 24.918% |
| Abbott Laboratories | 20 | 0 | 2 | 0 | €94.69 | €115.65 | 22.134% |
| Eli Lilly Corp. | 78 | 0 | 30 | 0 | €832.50 | €895.00 | 7.508% |
| Viatris Inc. | 3 | 0 | 2 | 0 | €9.73 | €12.25 | 25.873% |
| Perrigo Co. plc | 4 | 0 | 1 | 0 | €24.18 | €35.01 | 44.770% |